CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  He, Ke Fei ^a   Zhang, Lu ^a   Huang, Cong Fa ^a   Ma, Si Rui ^a   Wang, Yu Fan ^a   Wang, Wei Ming ^a   Zhao, Zhi Li ^a   Liu, Bing ^a,b   Zhao, Yi Fang ^a,b   Zhang, Wen Feng ^b   Sun, Zhi Jun ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD163 ANTIGEN; CD68 ANTIGEN; HERMES ANTIGEN; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; ISOENZYME; LEUKOCYTE ANTIGEN; RETINAL DEHYDROGENASE; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CONTROLLED STUDY; DYSPLASIA; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; ORAL EPITHELIAL DYSPLASIA; OVERALL SURVIVAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MACROPHAGE; METABOLISM; MOUTH NEOPLASMS; PATHOLOGY; PROGNOSIS;

ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MOUTH NEOPLASMS; NEOPLASTIC STEM CELLS; PROGNOSIS; RECEPTORS, CELL SURFACE; RETINAL DEHYDROGENASE; SOXB1 TRANSCRIPTION FACTORS;

EID: 84901773880     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/838632     Document Type: Article

References (33)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Quan J., Johnson N. W., Zhou G., Parsons P. G., Boyle G. M., Gao J., Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms. Cancer and Metastasis Reviews 2011 31 1-2 209 219 2-s2.0-81555229908 10.1007/s10555-011-9335-7
3. Visvader J. E., Lindeman G. J., Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012 10 6 717 728 10.1016/j.stem.2012.05. 007
4. Lathia J. D., Heddleston J. M., Venere M., Rich J. N., Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 2011 8 5 482 485 2-s2.0-79955702339 10.1016/j.stem.2011.04.013
5. Wang Y.-C., Yo Y.-T., Lee H.-Y., Liao Y.-P., Chao T.-K., Su P.-H., Lai H.-C., ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. American Journal of Pathology 2012 180 3 1159 1169 2-s2.0-84857230379 10.1016/j.ajpath.2011.11.015
6. Sonobe S., Miyamoto H., Nobukawa B., Izumi H., Futagawa T., Ishikawa N., Yamazaki A., Uekusa T., Abe H., Suda K., Prognostic value of CD44 isoform expression in thymic epithelial neoplasms. Cancer 2005 103 10 2015 2022 2-s2.0-18044380673 10.1002/cncr.21046 (Pubitemid 40605107)
7. Tang X. B., Shen X. H., Li L., Zhang Y. F., Chen G. Q., SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx 2013 40 5 481 486 10.1016/j.anl.2013.01.003
8. Du L., Yang Y., Xiao X., Wang C., Zhang X., Wang L., Zhang X., Li W., Zheng G., Wang S., Dong Z., Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncology 2011 47 8 709 713 2-s2.0-79960696915 10.1016/j.oraloncology.2011.05.017
9. Liu K., Lin B., Zhao M., Yang X., Chen M., Gao A., Liu F., Que J., Lan X., The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cellular Signalling 2013 25 5 1264 1271 10.1016/j.cellsig.2013.02.013
10. Fessler E., Dijkgraaf F. E., de Sousa E. M. F., Medema J. P., Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame? Cancer Letters 2013 34 1 97 104 10.1016/j.canlet.2012.10.015
11. Tang X., Mo C., Wang Y., Wei D., Xiao H., Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology 2013 138 2 93 104 10.1111/imm.12023
12. Signer R. A., Morrison S. J., Mechanisms that regulate stem cell aging and life span. Cell Stem Cell 2013 12 2 152 165 10.1016/j.stem.2013.01.001
13. Hao N. B., Lu M. H., Fan Y. H., Cao Y. L., Zhang Z. R., Yang S. M., Macrophages in tumor microenvironments and the progression of tumors. Clinical and Developmental Immunology 2012 2012 11 948098 10.1155/2012/948098
14. Shi C., Pamer E. G., Monocyte recruitment during infection and inflammation. Nature Reviews Immunology 2011 11 11 762 774 2-s2.0-80355146868 10.1038/nri3070
15. Maniecki M. B., Etzerodt A., Ulhøi B. P., Steiniche T., Borre M., Dyrskjøt L., Ørntoft T. F., Moestrup S. K., Møller H. J., Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. International Journal of Cancer 2012 131 10 2320 2331 2-s2.0-84858990193 10.1002/ijc.27506
16. Richards D. M., Hettinger J., Feuerer M., Monocytes and macrophages in cancer: development and functions. Cancer Microenvironment 2013 6 2 179 191
17. de Palma M., Lewis C. E., Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013 23 3 277 286 10.1016/j.ccr.2013.02.013
18. Medrek C., Ponten F., Jirstrom K., Leandersson K., The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012 12, article 306
19. Huang C. F., Zhang L., Ma S. R., Zhao Z. L., Wang W. M., He K. F., Zhao Y. F., Zhang W. F., Liu B., Sun Z. J., Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma. PLoS ONE 2013 8 12 e83479
20. Sun Z. J., Zhang L., Hall B., Bian Y., Gutkind J. S., Kulkarni A. B., Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clinical Cancer Research 2012 18 19 5304 5313 10.1158/1078-0432.CCR-12-1371
21. Takakura N., Formation and regulation of the cancer stem cell niche. Cancer Science 2012 103 7 1177 1181 2-s2.0-84859509364 10.1111/j.1349-7006.2012. 02270.x
22. Ruffell B., Affara N. I., Coussens L. M., Differential macrophage programming in the tumor microenvironment. Trends in Immunology 2012 33 3 119 126 2-s2.0-84857692141 10.1016/j.it.2011.12.001
23. Joyce J. A., Pollard J. W., Microenvironmental regulation of metastasis. Nature Reviews Cancer 2009 9 4 239 252 2-s2.0-63049104211 10.1038/nrc2618
24. McCubrey J. A., Steelman L. S., Abrams S. L., Misaghian N., Chappell W. H., Bäsecke J., Nicoletti F., Libra M., Ligresti G., Stivala F., Maksimovic-Ivanic D., Mijatovic S., Montalto G., Cervello M., Laidler P., Bonati A., Evangelisti C., Cocco L., Martelli A. M., Targeting the cancer initiating cell: the ultimate target for cancer therapy. Current Pharmaceutical Design 2012 18 13 1784 1795 2-s2.0-84860146509 10.2174/138161212799859701
25. Bourguignon L. Y., Wong G., Earle C., Chen L., Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. The Journal of Biological Chemistry 2012 287 39 32800 32824 10.1074/jbc.M111.308528
26. Zeyda M., Gollinger K., Todoric J., Kiefer F. W., Keck M., Aszmann O., Prager G., Zlabinger G. J., Petzelbauer P., Stulnig T. M., Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology 2011 152 6 2219 2227 2-s2.0-79956324407 10.1210/en.2010-1328
27. Sanford D. E., Belt B. A., Panni R. Z., Mayer A., Deshpande A. D., Carpenter D., Mitchem J. B., Plambeck-Suess S. M., Worley L. A., Goetz B. D., Wang-Gillam A., Eberlein T. J., Denardo D. G., Goedegebuure S. P., Linehan D. C., Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clinical Cancer Research 2013 19 13 3404 3415 10.1158/1078-0432.CCR-13-0525
28. Komohara Y., Ohnishi K., Kuratsu J., Takeya M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. Journal of Pathology 2008 216 1 15 24 2-s2.0-50249144131 10.1002/path.2370
29. Shabo I., Stål O., Olsson H., Doré S., Svanvik J., Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. International Journal of Cancer 2008 123 4 780 786 2-s2.0-47049108919 10.1002/ijc.23527 (Pubitemid 352032402)
30. Shabo I., Olsson H., Sun X.-F., Svanvik J., Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. International Journal of Cancer 2009 125 8 1826 1831 2-s2.0-70349259469 10.1002/ijc.24506
31. Kong L. Q., Zhu X. D., Xu H. X., Zhang J. B., Lu L., Wang W. Q., Zhang Q. B., Wu W. Z., Wang L., Fan J., Tang Z. Y., Sun H. C., The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. PLoS ONE 2013 8 3 e59771
32. Yang J., Liao D., Chen C., Liu Y., Chuang T. H., Xiang R., Markowitz D., Reisfeld R. A., Luo Y., Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells 2013 31 2 248 258 10.1002/stem.1281
33. Jinushi M., Chiba S., Yoshiyama H., Masutomi K., Kinoshita I., Dosaka-Akita H., Yagita H., Takaoka A., Tahara H., Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proceedings of the National Academy of Sciences of the United States of America 2011 108 30 12425 12430 2-s2.0-79961074770 10.1073/pnas.1106645108